Skip to main navigation Skip to search Skip to main content

Toxicity evaluation of choline ionic liquid-based nanocarriers of pharmaceutical agents for lung treatment

  • Silesian University of Technology

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

In vitro cytotoxicity evaluation of linear copolymer (LC) containing choline ionic liquid units and its conjugates with an antibacterial drug in anionic form, that is, p-aminosalicylate (LC_PAS), clavulanate (LC_CLV), or piperacillin (LC_PIP) was carried out. These systems were tested against normal: human bronchial epithelial cells (BEAS-2B), and cancers: adenocarcinoma human alveolar basal epithelial cells (A549), and human non-small cell lung carcinoma cell line (H1299). Cells viability, after linear copolymer LC and their conjugates addition for 72 h, was measured at concentration range of 3.125–100 μg/mL. The MTT test allowed the designation of IC50 index, which was higher for BEAS-2B, and significantly lower in the case of cancer cell lines. The cytometric analyzes, that is, Annexin-V FITC apoptosis assay and cell cycle analysis as well as gene expression measurements for interleukins IL6 and IL8 were carried out, and showed pro-inflammatory activity of tested compounds toward cancer cells, while it was not observed against normal cell line.

Original languageEnglish
Pages (from-to)1374-1385
Number of pages12
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume111
Issue number7
DOIs
Publication statusPublished - Jul 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cytotoxicity
  • drug delivery systems
  • ionic conjugates
  • polymer nanocarriers
  • trimethylammonium ionic liquids

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Toxicity evaluation of choline ionic liquid-based nanocarriers of pharmaceutical agents for lung treatment'. Together they form a unique fingerprint.

Cite this